observed that pan‐RAF plus MEK inhibitors had a significant growth inhibition in the majority of the NRAS‐mutant melanoma cell lines; meanwhile, these inhibitors exhibited high levels of synergism [188]. This evidence concerns the gene NRAS and melanoma.